FimAsartaN proTeinuriA SusTaIned reduCtion in comparison with losartan in diabetic chronic kidney disease (FANTASTIC): study protocol for randomized controlled trial

BACKGROUND: Fimasartan is the ninth angiotensin receptor blocker to be developed. However, it has not yet been evaluated for reno-protective effects in hypertensive diabetic chronic kidney disease (CKD). The target blood pressure (BP) for hypertensive diabetic CKD is also a controversial topic. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jang-Young, Son, Jung-Woo, Park, Sungha, Yoo, Tea-Hyun, Kim, Yong-Jin, Ryu, Dong-Ryeol, Chin, Ho Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747165/
https://www.ncbi.nlm.nih.gov/pubmed/29284530
http://dx.doi.org/10.1186/s13063-017-2375-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747165/
https://www.ncbi.nlm.nih.gov/pubmed/29284530
http://dx.doi.org/10.1186/s13063-017-2375-8

Ejemplares similares